Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stomach Neoplasms × Etoposide × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 124 Lymphoma, Large B-Cell, Diffuse 77 Lymphoma, Non-Hodgkin 75 Small Cell Lung Carcinoma 70 Hodgkin Disease 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Leukemia 53 Burkitt Lymphoma 52 Lung Neoplasms 46 Lymphoma, Follicular 43 Lymphoma, Mantle-Cell 39 Lymphoma, Large-Cell, Immunoblastic 38 Leukemia, Myeloid, Acute 37 Leukemia, Lymphocytic, Chronic, B-Cell 33 Multiple Myeloma 29 Carcinoma, Non-Small-Cell Lung 26 Recurrence 24 Lymphoma, B-Cell, Marginal Zone 24 Neuroblastoma 21 Central Nervous System Neoplasms 20 Ovarian Neoplasms 17 Sarcoma 16 Dendritic Cell Sarcoma, Interdigitating 16 Congenital Abnormalities 15 Breast Neoplasms 15 Brain Neoplasms 15 Neoplasms, Plasma Cell 14 Myelodysplastic Syndromes 13 Lymphoma, Large-Cell, Anaplastic 13 Neoplasms 12

Interventions

Oxaliplatin 154 Capecitabine 104 Fluorouracil 91 Docetaxel 77 Cisplatin 76 S 1 (combination) 74 Leucovorin 63 Paclitaxel 52 Irinotecan 51 pembrolizumab 34 Trastuzumab 31 apatinib 29 sintilimab 28 Bevacizumab 20 Surgical Procedures, Operative 19 Radiotherapy 19 camrelizumab 15 Ramucirumab 14 Nivolumab 14 titanium silicide 13 tislelizumab 13 Drug Therapy 13 Hyperthermic Intraperitoneal Chemotherapy 12 Folfox protocol 12 Epirubicin 12 Cetuximab 12 Tegafur 10 Carboplatin 10 XELOX 9 HMPL-013 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02949258 2016-10-31

NCT-B4

Jinling Hospital, China

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡